ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) (www.biomoda.com) today announced that John Cousins, President and CEO, will present on Biomoda’s proprietary CyPath® diagnostic assay for the detection of early-stage cancers at the Rodman & Renshaw 12th Annual Healthcare Conference in New York on Wednesday, September 15, 2010.
